Studies have demonstrated impaired FGF21 signaling in the liver, pancreas, and white adipose tissue of obese mice (Fisher et al., 2010; So et al., 2013), initially suggesting that obesity is an FGF21-resistant state. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.